Cognitive functioning in stabilized first-episode psychosis patients - PubMed (original) (raw)
Cognitive functioning in stabilized first-episode psychosis patients
L A Townsend et al. Psychiatry Res. 2001.
Abstract
This paper describes the cognitive functioning of a community cohort of individuals presenting with a first episode of a schizophrenia spectrum psychosis. Data were obtained for 107 patients (mean age 25 years) following stabilization of acute psychotic symptoms, mostly with the use of novel antipsychotics, on measures of intellectual, memory, attentional and executive functioning using a standardized battery of cognitive measures, including WAIS III and WMS III. While patients generally performed in the average range across the majority of measures, deficits (Z-scores >1.0 S.D.) were observed on measures of speed of information processing (PASAT, WAIS III) and executive functions (Stroop Test and Trails B), with the greatest deficits observed on tests of processing speed (PASAT). Discrepancy scores between the NART and the WAIS suggest subtle but statistically significant declines in full scale and performance IQ following onset of psychosis. Differences in cognitive functioning between diagnostic groups were not supported. Comparison of the highest and lowest functioning patients with respect to the cognitive measures also did not support any demographic or clinical differences between these two subgroups. Our results suggest a relatively benign cognitive profile in first-episode schizophrenia spectrum psychosis, regardless of diagnosis, when most potential incidence cases in the community are included. The most severe deficits reported were on measures of speeded information processing, and level of performance did not distinguish between patients demographically or clinically.
Similar articles
- [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
Lecardeur L, Meunier-Cussac S, Dollfus S. Lecardeur L, et al. Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Encephale. 2013. PMID: 23528322 Review. French. - [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B. Bralet MC, et al. Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French. - Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JM, Woerner MG, Geisler S, Kane JM, Lieberman JA. Bilder RM, et al. Am J Psychiatry. 2000 Apr;157(4):549-59. doi: 10.1176/appi.ajp.157.4.549. Am J Psychiatry. 2000. PMID: 10739413 - Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
Harvey PD, Rabinowitz J, Eerdekens M, Davidson M. Harvey PD, et al. Am J Psychiatry. 2005 Oct;162(10):1888-95. doi: 10.1176/appi.ajp.162.10.1888. Am J Psychiatry. 2005. PMID: 16199835 Clinical Trial. - [Specialised first-episode psychosis services: a systematic review of the literature].
Skalli L, Nicole L. Skalli L, et al. Encephale. 2011 May;37 Suppl 1:S66-76. doi: 10.1016/j.encep.2010.08.004. Epub 2010 Oct 12. Encephale. 2011. PMID: 21600336 Review. French.
Cited by
- Cognitive and Social Rehabilitation in Schizophrenia-From Neurophysiology to Neuromodulation. Pilot Study.
Markiewicz R, Dobrowolska B. Markiewicz R, et al. Int J Environ Res Public Health. 2020 Jun 5;17(11):4034. doi: 10.3390/ijerph17114034. Int J Environ Res Public Health. 2020. PMID: 32517043 Free PMC article. - Should cognitive deficit be a diagnostic criterion for schizophrenia?
Lewis R. Lewis R. J Psychiatry Neurosci. 2004 Mar;29(2):102-13. J Psychiatry Neurosci. 2004. PMID: 15069464 Free PMC article. Review. - Cognitive functioning and negative symptoms in first episode schizophrenia: different patterns of correlates.
Rodríguez-Sánchez JM, Crespo-Facorro B, González-Blanch C, Pérez-Iglesias R, Alvarez-Jiménez M, Martínez O, Vázquez-Barquero JL. Rodríguez-Sánchez JM, et al. Neurotox Res. 2008 Oct;14(2-3):227-35. doi: 10.1007/BF03033812. Neurotox Res. 2008. PMID: 19073428 - Cognitive control deficits in schizophrenia: mechanisms and meaning.
Lesh TA, Niendam TA, Minzenberg MJ, Carter CS. Lesh TA, et al. Neuropsychopharmacology. 2011 Jan;36(1):316-38. doi: 10.1038/npp.2010.156. Epub 2010 Sep 15. Neuropsychopharmacology. 2011. PMID: 20844478 Free PMC article. Review. - The continuing story of schizophrenia and schizoaffective disorder: One condition or two?
Hartman LI, Heinrichs RW, Mashhadi F. Hartman LI, et al. Schizophr Res Cogn. 2019 Feb 10;16:36-42. doi: 10.1016/j.scog.2019.01.001. eCollection 2019 Jun. Schizophr Res Cogn. 2019. PMID: 30792965 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical